Second Amendment to Lease by and between Bulfinch Square Limited Partnership and Leap Therapeutics, Inc. dated as of October 1, 2021
Exhibit 10.27
SECOND AMENDMENT TO LEASE
This is a Second Amendment to Lease dated as of October 1, 2021 by and between Bulfinch Square Limited Partnership, a Massachusetts limited partnership ("Landlord") and Leap Therapeutics, Inc., a Delaware corporation ("Tenant").
WHEREAS, Landlord and Tenant entered into a Lease dated November 13, 2018, as amended by First Amendment to Lease dated August 17, 2021 (as so amended, the "Lease") with respect to certain premises at 47 Thorndike Street, Cambridge, Massachusetts; and
WHEREAS, Tenant wishes to delay until May 31 , 2022 the date by which it can give an Election Notice to extend the term of the Lease for the Extended Term; and
WHEREAS, Landlord is willing to agree to such a delay in return for an extension of the Original Tenn until January 31, 2023.
NOW, THEREFORE, in consideration of the foregoing, Landlord and Tenant agree as follows:
IN WITNESS WHEREOF, Landlord and Tenant have executed this First Amendment to Lease as of the date first set forth above.
LANDLORD: | |||
| |||
Bulfinch Square Limited Partnership | |||
| |||
By: | Courthouse Associates, Inc., its general partner | ||
Kenneth Krozy | |||
Vice President |
TENANT: | ||
| ||
Leap Therapeutics, Inc. | ||
| ||
BB By: | /s/ DOUGLAS E. ONSI | |
Nam . ouglas E. Onsi | ||
Title: President & CEO |